The Impact of Lifestyle Medicine on the Sense Of Coherence and Biological Age in a Community Sample (PSAI)

National and Kapodistrian University of Athens

Status: Completed

Conditions: Healthy Volunteers Only; Healthy Adults

Treatments: Behavioral: PSAI; Other: Usual Care

Study type: Interventional

Funder types: Other

Identifiers

NCT06671301

2401 (Other Identifier)

Details and patient eligibility

About

This two-arm, pilot, cross-over randomized controlled trial took place at Diabetes Laboratory, First Department of Propaedeutic Internal Medicine, Laikon General Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece the from February 2024 to June of 2024. The study protocol was approved by the Ethics Committee of First Department of Propaedeutic Internal Medicine, Laiko General Hospital(Protocol no 2401/February 27,2024)and was consistent with the Helsinki Declaration for human studies.

Full description

Pythagorean Self-Awareness Intervention (PSAI) to a sample of community volunteers without pre-existing pathology, with the aim of evaluating the effectiveness of PSAI compared to a control group. Primary goals are to improve lifestyle (6 pillars), increase sense of coherence, improve telomere length and reduce perceived stress. Secondary goals are to reduce negative emotions, fatigue, neuroticism and inflammation. Also, the increase in self-efficacy, emotional intelligence, health locus of control, satisfaction with life and finally the improvement of memory and blood pressure. Measurements will take place in both groups before and after the intervention and included: Self-report questionnaires for measuring psychometric and lifestyle factors, cognitive assessment, body measurements, hair cortisol concentrations and blood sampling for telomere length.

Enrollment: 40 patients

Sex: All

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Clinically healthy adults
• Speaking and writing in Greek language

Exclusion criteria

• Participation in another stress management trial
• diagnosis of any serious mental disorder
• short-term or long-term treatment with corticosteroids
• drug addiction

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

40 participants in 2 patient groups

PSAI group

Experimental group

Description:

Behavioural counselling

Treatment:

Behavioral: PSAI

Control group

Other group

Description:

No intervention used

Treatment:

Other: Usual Care